Plexium Debuts With $28M and a New Take on Protein Degradation Drugs

Even as researchers discover more links between specific proteins and human disease, it?s still hard to find small molecules or antibodies that can bind to those drug targets. San Diego biotech Plexium is the latest addition to the growing number of startups aiming to use technology to devise new drugs that can target those currently [?]